Earnings Call Transcripts

Access detailed transcripts and key takeaways from company earnings calls

All Earnings Calls

CARS May 7, 2026

Cars.com Q1 2026 Earnings Call - AI Integrations and Cost Cuts Drive Margin Expansion

Cars.com delivered a solid start to 2026, posting $180.2 million in revenue and beating adjusted EBITDA margin guidance at 28.3%. The company is actively restructuring its sales and product teams to s...

  • Q1 revenue came in at $180.2 million, up 1% year-over-year, landing at the high end of guidance and marking the third consecutive quarter of growth.
  • Adjusted EBITDA margin hit 28.3%, beating guidance by over a full percentage point, driven by lower depreciation and efficient marketing spend.
  • Management announced a restructuring initiative targeting $25 to $30 million in annualized operating cost savings, with benefits starting to flow through in Q2.
  • +10 more takeaways
ROCK May 7, 2026

Gibraltar Industries Q1 2026 Earnings Call - Omnimax Integration Drives Sales Surge Amid Commodity Headwinds

Gibraltar Industries reported a dynamic first quarter, with adjusted net sales jumping 44.6% to $356 million, fueled by two months of Omnimax operations and recent metal roofing acquisitions. However,...

  • Adjusted net sales surged 44.6% to $356 million, driven by two months of Omnimax integration and metal roofing acquisitions.
  • Adjusted EBITDA grew 16.1% to offset a 50% drop in adjusted EPS, heavily impacted by $14.6 million in net interest expenses.
  • Aluminum prices spiked 16% during the quarter, creating a $9-10 million headwind that management is working to recover through price increases.
  • +7 more takeaways
SPB May 7, 2026

Spectrum Brands Holdings Q2 2026 Earnings Call - Return to Growth Amidst Strategic HPC Separation

Spectrum Brands Holdings delivered a strong second quarter, marking its first return to year-over-year growth since early 2025. Net sales rose 4.9% and adjusted EBITDA surged 17.8%, driven by resilien...

  • Net sales increased 4.9% year-over-year, with organic growth of 1.5% excluding favorable foreign exchange, marking a return to growth for the first time since Q1 2025.
  • Adjusted EBITDA surged 17.8% to $84 million, driven by a 60 basis point expansion in gross margin to 38.1% and disciplined expense management.
  • Global Pet Care reported organic sales growth of 7.6%, with key brands like DreamBone and Nature’s Miracle outperforming flat or declining categories.
  • +7 more takeaways
HTZ May 7, 2026

Hertz Global Holdings Q1 2026 Earnings Call - Revenue Surges 11% as Mobility Platform 'Oro' Launches

Hertz delivered its strongest quarterly revenue growth in three years, with Q1 2026 revenue rising 11% year-over-year to $2.0 billion, driven by a 4.5% increase in revenue per unit (RPU) and a 5.5% ri...

  • Hertz reported Q1 2026 revenue of $2.0 billion, an 11% year-over-year increase, marking its strongest quarterly growth in three years and beating consensus expectations.
  • Adjusted corporate EBITDA surged by $141 million year-over-year, reflecting a nearly 50% improvement and demonstrating the effectiveness of Hertz's commercial strategy despite operational headwinds.
  • Revenue per unit (RPU) increased by 4.5% and revenue per day (RPD) rose by 5.5%, with U.S. airports showing particularly strong RPD growth of approximately 8%, signaling successful pricing and demand generation tactics.
  • +7 more takeaways
PVLA May 7, 2026

Palvella Therapeutics Q1 2026 Earnings Call - Positive Phase III Data for QTORIN Rapamycin in Microcystic Lymphatic Malformations

Palvella Therapeutics reported a defining quarter as its Phase III SELVA trial for QTORIN rapamycin in microcystic lymphatic malformations (MLM) successfully met all primary and secondary endpoints. T...

  • Phase III SELVA trial for QTORIN rapamycin in microcystic lymphatic malformations (MLM) met all primary and secondary endpoints, demonstrating a safety and tolerability profile suitable for first-line standard of care positioning.
  • NDA submission for QTORIN rapamycin in MLM is on track for the second half of 2026, with an in-person pre-NDA meeting granted by the FDA later this quarter.
  • Palvella completed an upsized $230 million equity financing in February, providing sufficient cash to fund launch readiness and pipeline development through potential commercialization.
  • +11 more takeaways
FG May 7, 2026

F&G First Quarter 2026 Earnings Call - Record AUM Growth and Strategic Pivot to Higher-Margin Fee Income

F&G delivered a solid first quarter, achieving record gross AUM of nearly $75 billion and adjusted net earnings of $110 million. The company is intentionally shifting its business model toward a more ...

  • Record gross AUM reached nearly $75 billion, up 11% year-over-year, driven by strong core sales in retail indexed annuities, indexed universal life, and pension risk transfer.
  • Adjusted net earnings came in at $110 million, or $0.82 per share, in line with management expectations despite a $5 million unfavorable significant item.
  • F&G is executing a strategic pivot toward a capital-light, fee-based business model. Fee-driven strategies are expected to grow from 15% of adjusted net earnings in 2025 to 25% by 2028, targeting higher ROE.
  • +7 more takeaways
CMP May 7, 2026

Compass Minerals Q2 FY2026 Earnings Call - Plant Nutrition Surges as Salt Costs Lag and Debt Falls

Compass Minerals delivered a quarter of mixed signals. The Plant Nutrition business surged, with adjusted EBITDA jumping over 200% year-over-year, driven by better operational execution at the Ogden f...

  • Compass Minerals retired its final $150 million tranche of 2027 senior unsecured notes ahead of schedule, using cash on hand to remove its nearest debt maturity and extend its refinancing runway into 2028.
  • Net debt fell to $639 million at quarter-end, down $119 million year-over-year, while the leverage ratio improved sharply to 2.7 times from 4.6 times a year ago.
  • Plant Nutrition adjusted EBITDA exploded 202% year-over-year to $17 million, with margins expanding to 25.2% from 9.6%, driven by superior execution at the Ogden facility and a favorable sales mix.
  • +7 more takeaways
BKD May 7, 2026

Brookdale Senior Living Q1 2026 Earnings Call - Restructuring and Portfolio Cleanup Drive Margin Expansion

Brookdale Senior Living’s first quarter 2026 results reflect a company in the midst of a deliberate, disruptive transformation. CEO Nick Stengle highlighted a structural pivot toward an operating-firs...

  • Brookdale Senior Living reported Q1 2026 Adjusted EBITDA of $131 million, a 5.6% increase year-over-year, despite a 14% decline in consolidated average units due to ongoing dispositions.
  • Consolidated occupancy reached 82.1%, up 280 basis points year-over-year, with same-community occupancy at 82.7%, up 170 basis points. April occupancy showed stronger sequential growth (+30 bps) than historical averages, signaling improved execution.
  • The company maintained full-year 2026 guidance of 8-9% RevPAR growth and $502-516 million in Adjusted EBITDA, with management expecting mid-teens Adjusted EBITDA growth from a 2025 baseline of $445 million.
  • +9 more takeaways
GFI May 7, 2026

Gold Fields Q1 2026 Earnings Call - Austerity in the Spotlight Amidst Cost Pressures

Gold Fields delivered a solid start to 2026 with 15% higher gold equivalent production, driven by strong performance at Salares Norte. However, the company faces mounting cost pressures, with all-in s...

  • Gold Fields reported a 15% year-over-year increase in gold equivalent production for Q1 2026, totaling 633,000 ounces, driven by strong performance at Salares Norte.
  • All-in sustaining costs rose 13% year-over-year to $1,829 per ounce, primarily due to higher royalties, currency fluctuations, and inflation.
  • Management remains confident in meeting full-year production and cost guidance, despite operational challenges at Gruyere, Agnew, and Tarkwa.
  • +7 more takeaways
VVV May 7, 2026

Valvoline Q2 2026 Earnings Call - Defensive Service Model Delivers 25% Sales Growth Amid Geopolitical Uncertainty

Valvoline's Q2 2026 results showcase a business model that thrives on non-discretionary demand and operational leverage. Net sales surged 25% to $504 million, driven by robust same-store sales growth ...

  • Net sales grew 25% year-over-year to $504 million, outpacing expectations due to strong system-wide performance and Breeze Autocare inclusion.
  • Same-store sales increased 8.2%, with two-thirds driven by ticket growth from net pricing, premiumization, and NOCR penetration; transactions also expanded.
  • EBITDA rose 28% to $134 million, with margin expanding 60 basis points to 26.5% as SG&A leverage improved despite new store depreciation.
  • +7 more takeaways